ArticleSignal transduction and targeted therapy2026
RAF1 extrachromosomal DNA amplification confers acquired erlotinib resistance in a non-small cell lung cancer cell model.
Sujin Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.